Skip to main content
Back to Database
Anaphylaxis InsuranceEnactedState Checked 8/13/2026 Unrelated Link

An Act concerning coverage for epinephrine auto-injector devices and asthma inhalers

New Jersey P.L. 2023, c. 105 2023 Co-sponsors: McKeon, Mukherji, Murphy
VV
Primary Sponsor
Vitale
Co-sponsors: McKeon, Mukherji, Murphy

Transparency & Verification

Verified from Official Source
Source AgencyNew Jersey Legislature
Last Updated2026-07-22
Last Verified2026-08-13
Verified ByPolicyPantry Research System
Official Source URL https://pub.njleg.state.nj.us/Bills/2022/PL23/105_.HTM Link Unconfirmed — this source may not match this law (Unrelated)
Last checked: 2026-08-09 Confidence: 100/100 approved

Policy Pantry collects information from official and trusted public sources. Legislative information can change quickly. Always review the linked official government source for the most current details.

AI Plain-Language Summary

Click "Generate" to create an AI-powered plain-language summary of this legislation.

Summary

Caps out-of-pocket costs for a 30-day supply of epinephrine auto-injectors at $25 and asthma inhalers at $50 for state-regulated health insurance plans.

Who This Bill Serves & Who's Backing It

Core Patient Populations

[object Object] Anaphylaxis

People at risk of life-threatening anaphylaxis.

Advocacy Groups Backing This Legislation

No advocacy organizations are currently tracked as backing this bill.Browse advocacy organizations →

Legislative Timeline

Legislative Session2022-2023 Session
Introduced2022-05-26
CommitteeSenate Health, Human Services and Senior Citizens Committee

Votes & Legislative History

Legislative History & Resources

Committee HistoryPassed Senate Jun 20, 2023; Passed Assembly Jun 30, 2023; Signed by Governor Jul 10, 2023.
Legislative HistoryIntroduced May 26, 2022; Signed into law Jul 10, 2023; Effective Jan 1, 2025.

Take Action on This Law

Send a letter or generate testimony about this legislation.

Advocate Connect

See who's supporting this law, find advocates with shared goals, and combine advocacy efforts and letters to amplify your impact.

Log in to join as an advocate and connect with others supporting this law.

Be the first advocate to support this law and invite others to combine efforts.

Signed Into Law
AnaphylaxisEnacted
Signed into Law
Checked 10/11/2026 Link Unconfirmed Education

US Virgin Islands School Health Regulations

Virgin Islands Code, Title 17, Education

The US Virgin Islands Department of Education oversees school health policies, but there is no specific territory-wide mandate requiring schools to stock emergency epinephrine or provide standardized training for anaphylaxis management in K-12 settings.

US Virgin Islands N/A
Search Official Sources
Search for source
Signed Into Law
AnaphylaxisEnacted
Signed into Law
Checked 10/10/2026 Source Active Education

FASTER Act

Food Allergy Safety, Treatment, Education, and Research Act of 2021 (FASTER Act)

A federal law that recognizes sesame as the ninth major food allergen and mandates its labeling on packaged food products. It also directs federal research into food allergies, including FPIES and eosinophilic gastrointestinal diseases, which applies to all U.S. territories including Guam.

Guam S. 578
Official Government Source
Official Government Source
Signed Into Law
AnaphylaxisEnacted
Signed into Law
Checked 10/9/2026 Unrelated Link Education

Public Law 113-48

School Access to Emergency Epinephrine Act

A federal law that incentivizes states to allow schools to maintain a supply of stock epinephrine and train personnel to administer it to students experiencing anaphylaxis.

Guam S. 1884
Search Official Sources
Search for source

While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.

PolicyPantry

Connecting America to Allergy Knowledge, Laws, and Care.

Empowering advocates for allergy, asthma & anaphylaxis rights nationwide.

Follow @policypantry

Educational Disclaimer: The information on this platform is provided for general educational and informational purposes only. It is not medical advice and does not replace professional medical consultation, diagnosis, or treatment. Always seek the guidance of a qualified healthcare professional with any questions about a medical condition. If you are experiencing a medical emergency, call 911 immediately. While we strive for accuracy, please double-check and verify any information found here against official sources before relying on it.

Policy Pantry™ is a health policy technology platform empowering communities through legislation, advocacy, and innovation.

© 2026 Policy Pantry LLC. All Rights Reserved.